Estudo prospectivo das repercussões de baixas doses de remifentanil na função sinoatrial e na condução e refratariedade cardíaca
Prospective study on the repercussions of low doses of remifentanil on sinoatrial function and in cardiac conduction and refractory period
Simone Soares Leite; Elizabeth Bessadas Penna Firme; Márcia Santana Bevilaqua; Leonel dos Santos Pereira; Jacob Atié
Resumo
Palavras-chave
Abstract
Keywords
References
Glass PS, Gan TJ, Howell S. A review of the pharmacokinetics and pharmacodynamics of remifentanil. Anesth Analg. 1999;89:S7-14.
Nora FS, Fortis EAF. Remifentanil: Por que precisamos de outro opióide?. Rev Bras Anestesiol. 2001;51(146-159).
Shafer SL. New intravenous anesthetic: Remifentanil. ASA Refresher Course. 1996;24:243-255.
Egan TD. Pharmacokinetics and pharmacodynamics of remifentanil: an update in the year 2000. Curr Opin Anaesthesiol. 2000;13:449-455.
Videira RLR, Cruz JRS. Remifentanil na prática clínica. Rev Bras Anestesiol. 2004;54:114-128.
Thompson JP, Rowboteram DJ. Remifentanil: an opióide for the 21st century. Br J Anaesth. 1996;76:341-343.
Scott LJ, Perry CM. Spotlight on remifentanil for general anaesthesia. CNS Drugs. 2005;19(12):1069-74.
Bürkle H, Dunbar S, Van Aken H. Remifentanil: A novel, short-acting, mu-opioid. Anesth Analg. 1996;83:646-651.
Servin FS. Remifentanil: an update. Curr Opin Anaesthesiol. 2003;16:367-372.
Elliot P, O'Hare R, Bill KM. Severe cardiovascular depression with remifentanil. Anesth Analg. 2000;91:58-61.
Thompson JP, May AP, Russell J. Effect of remifentanil on the haemodynamic response to orotracheal intubation. Br J Anaesth. 1998;80:467-469.
Reid JE, Mirakhur RK. Bradycardia after administration of remifentanil. Br J Anesth. 2000;84:422-423.
DeSouza G, Lewis MC, TerRiet MF. Severe bradycardia after remifentanil. Anesthesiology. 1997;87:1019-1020.
Glass PSA. Pharmacology of remifentanil. Eur J Anaesthesiol. 1995;12(10):73-74.
Wang J, Winship S, Russell G. Induction of anaesthesia with sevoflurane and low-dose remifentanil: asystole following laryngoscopy. Br J Anestth. 1998;81:994-995.
Altermatt FR, Muñoz HR. Asystole with propofol and remifentanil. Br J Anesth. 2000;84:696-697.
Starr NJ, Sethna DH, Estafanous FG. Bradycardia and asystole following the rapid administration of sufentanil with vecuronium. Anesthesiology. 1986;64:521-523.
Maryniak JK, Bishop VA. Sinus arrest after alfentanil. Br J Anaesth. 1987;59:390-391.
Sherman EP, Lebowitz PW, Street WC. Bradycardia following sufentanil-succinylcholine. Anesthesiology. 1987;66.
Rivard JC, Lebowitz PW. Bradycardia after alfentanil-succinylcholine. Anesth Analg. 1988;67:907.
Egan TD, Brock-Utne JG. Asystole after anesthesia induction with fentanyl, propofol, and succinylcholine sequence. Anesth Analg. 1991;73:818-820.
Kennedy BL, West TC. Effect of morphine on electrically induced release of autonomic mediators in the rabbit sinoatrial node. J Pharmacol Exp Ther. 1967;157:149-158.
Tomichek RC, Rosow C, Philbin DM. Diazepan-fentanyl interaction hemodynamic and hormonal effects in coronary artery surgery. Anesth Analg. 1983;62:881-884.
Blair JR, Pruett JK, Introna RPS. Cardiac electrophysiologic effects of fentanyl and sufentanil in canine cardiac Purkinje fibers. Anesthesiology. 1989;71:565-570.
Puerto BA, Wong KC, Puerto AX. Epinephrine-induced dysrhythmias: Comparison during anaesthesia with narcotics and with halogenated agents in dogs. Can Anaesth Soc J. 1979;26:263-268.
Weber G, Stark G, Stark U. Direct cardiac electrophysiologic effects of sufentanil and vecuronium in isolated guinea-pig hearts. Acta Anaesthesiol Scand. 1995;39:1071-1074.
Reitan N, Stengert KB, Wymore ML. Central vagal control of fentanyl-induced bradycardia during halothane anesthesia. Anesth Analg. 1978;57:31-36.
Saeki T, Nishimura M, Sato N. Electrophysiological demonstration and activation of mu-opioid receptors in rabbit sinoatrial node. J Cardiovasc Pharmacol. 1995;26:160-168.
Gómes-Arnau J, Márquez-Montes J, Avello F. Fentanyl and droperidol effects on refractoriness of acessory pathways in the Wolff-Parkinson-White syndrome. Anesthesiology. 1983;58:307-313.
Sharpe MD, Dobkowski WB, Murkin JM. Alfentanil-midazolam anaesthesia has no electrophysiological effects upon the normal conduction system or accessory pathways in patients with Wolff-Parkinson-White syndrome. Can J Anaesth. 1992;39:816-821.
Sharpe MD., Dobkowski WB, Murkin JM. The electrophysiologic effects of volatile anesthetics and sulfentanil on the normal atrioventricular conduction system and accessory pathways in Wolff-Parkinson-White syndrome. Anesthesiology. 1994;80:63-70.
Sebel PS, Hoke JF, Westmoreland C. Histamine concentrations and haemodynamic responses after remifentanil. Anesth Analg. 1995;80:990-993.
Unlugenc H, Itegin M, Ocal I. Remifentanil produces vasorelaxation in isolated rat thoracic aorta strips. Acta Anaesthesiol Scand. 2003;47:65-69.
Shinohara K, Aodo H, Uruh GK. Suppressive effects of remifentanil on aerodynamics in baro-denervated rabbits. Can J Anaesth. 2000;47:361-366.
Josephson ME. Clinical Cardiac Eletrophysiology: Techniques and Interpretation. 2002:6-166.
Atlee JL, Bosnjak ZJ. Mechanism for cardiac dysrhythimias during anesthesia. Anesthesiology. 1990;72:347-374.
Gold MI, Watkins W, David MD. Remifentanil versus remifentanil/midazolam for ambulatory surgery during monitored anesthesia care. Anesthesiology. 1997;87:51-57.
Avramov MN, Smith IMB, White PF. Interactions between midazolam and remifentanil during monitored anesthesia care. Anesthesiology. 1996;85:1283-1289.